Pharmacological Predictors of Outcome:
- can they be used to treat or prevent resistance?
- what is their role in drug development?

organized within the 2006 Annual Conference on Antimicrobial Resistance (SCIENCE • PREVENTION • CONTROL)
National Foundation for Infectious Diseases, Bethesda MD
June 26 – 28, 2006 - Hyatt Regency Bethesda • Bethesda

Note: The slides presented by the some of the speakers at this symposium are available on this site as "Web slide shows" and as ".PDF files". To view and/or to download them, click on the title of the lectures. These slides, which reflect the views of their authors and should not be taken as being endorsed by ISAP, are for information purposes only. They cannot be reproduced or used for any form of presentations without the autorization of their author and of ISAP. Please, contact the ISAP Webmaster for further information.


  • The Role of Pharmacological Predictors in Drug Development WEB - PDF
    Hartmut Derendorf, Ph.D. (University of Florida, Gainesville, FL)
  • Use of Pharmacologic Predictors in Prevention or Treatment of Resistance
    Otto Cars, M.D., Ph.D. (Swedish Institute for Infectious Diseases, Solna, Sweden)
  • The Influence of Tissue Distribution and Protein Binding on Resistance
    Ursula Theuretzbacher, Ph.D (Center for Anti-Infective Agents, Vienna, Austria) PDF
  • The Influence of Duration of Therapy on Resistance
    Johan Mouton, M.D., Ph.D. (Medical Microbiology and Infectious Diseases, W. Casinius Hospital, Nijmegen, The Netherlands)

Useful links


Back to ISAP home page



Credits:

last significant update: December 30, 2005